mitoxantrone has been researched along with Intracranial Hemorrhages in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Intracranial Hemorrhages: Bleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taube, F | 1 |
| Stölzel, F | 1 |
| Thiede, C | 1 |
| Ehninger, G | 1 |
| Laniado, M | 1 |
| Schaich, M | 1 |
1 other study available for mitoxantrone and Intracranial Hemorrhages
| Article | Year |
|---|---|
Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
Topics: Antineoplastic Agents; Female; Humans; Intracranial Hemorrhages; Leukemia, Promyelocytic, Acute; Mid | 2011 |